Skip to content

Fusobacterium nucleatum in oral cavity and colon of patients with cororectal cancer

Fusobacterium nucleatum in oral cavity and colon of patients with cororectal cancer - Fusobacterium nucleatum in oral cavity and colon of patients with cororectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016229
Enrollment
100
Registered
2015-01-16
Start date
2015-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Sponsors

Yokohama City University Gastroenterology and Hepatorogy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patient present with colorectal cancer subject without colorectal tumor as controls

Exclusion criteria

Exclusion criteria: 1 patient with inflammatory bowel disease or any other disease of bowel inflammation 2 history of heart failure, renal failure, liver cirrhosis or chronic hepatic failure 3 history of abnormal blood clotting 4 risk of complication of biopsy due to antiplatelet drug or anticoanrants 5 patients who we can not get written informed consent from 6 patients judged as being inappropriate candidates for the trial by the investigators

Design outcomes

Primary

MeasureTime frame
the homology of Fusobacterium nucleatum in oral cavity and colon

Secondary

MeasureTime frame
the homology of Fusobacterium nucleatum in colorectal cancer patients and healthy controls

Countries

Japan

Contacts

Public ContactShotaro Umezawa

Yokohama City University Gastroenterology and Hepatorogy

umezawa-ykh@umin.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026